NCT00126724: Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects |
|
|
| Completed | 1/2 | 120 | US | tgAAC94 gene therapy vector, tgAAC94 placebo | Targeted Genetics Corporation | Arthritis, Rheumatoid, Arthritis, Psoriatic, Ankylosing Spondylitis | 10/08 | 05/09 | | |
